CHAPTER IANNUAL PROGRAMMES

Article 4Bluetongue in endemic or high risk areas

1.

The programmes for the eradication and monitoring of bluetongue submitted by Belgium, Bulgaria, the Czech Republic, Denmark, Germany, Estonia, Ireland, Greece, Spain, France, Italy, Latvia, Lithuania, Hungary, Malta, the Netherlands, Austria, Poland, Portugal, Romania, Slovenia, Slovakia, Finland and Sweden are hereby approved for the period from 1 January 2011 to 31 December 2011.

2.

The financial contribution by the Union:

(a)

shall include a lump sum of EUR 0,5 per domestic animal sampled;

(b)

shall be at the rate of F160 % of the costs to be incurred by each Member State referred to in paragraph 1 for:

  1. (i)

    the cost of carrying out the vaccination;

  2. (ii)

    the cost of carrying out laboratory tests for virological, serological and entomological surveillance;

  3. (iii)

    the purchase of traps and vaccines; and

F1(c)

shall not exceed the following:

  1. (i)

    EUR  420 000 for Belgium;

  2. (ii)

    EUR  10 000 for Bulgaria;

  3. (iii)

    EUR  1 700 000 for the Czech Republic;

  4. (iv)

    EUR 0 for Denmark;

  5. (v)

    EUR  400 000 for Germany;

  6. (vi)

    EUR  10 000 for Estonia;

  7. (vii)

    EUR  10 000 for Ireland;

  8. (viii)

    EUR  100 000 for Greece;

  9. (ix)

    EUR  5 200 000 for Spain;

  10. (x)

    EUR  3 000 000 for France;

  11. (xi)

    EUR  300 000 for Italy;

  12. (xii)

    EUR  20 000 for Latvia;

  13. (xiii)

    EUR  5 000 for Lithuania;

  14. (xiv)

    EUR  60 000 for Hungary;

  15. (xv)

    EUR  10 000 for Malta;

  16. (xvi)

    EUR  50 000 for the Netherlands;

  17. (xvii)

    EUR  160 000 for Austria;

  18. (xviii)

    EUR  50 000 for Poland;

  19. (xix)

    EUR  1 650 000 for Portugal;

  20. (xx)

    EUR  100 000 for Romania;

  21. (xxi)

    EUR  50 000 for Slovenia;

  22. (xxii)

    EUR  60 000 for Slovakia;

  23. (xxiii)

    EUR  20 000 for Finland;

  24. (xxiv)

    EUR  20 000 for Sweden.

3.

The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed:

  • F1(a)for an ELISA test

    EUR 3 per test;

  • (b)for a PCR test

    EUR 12 per test;

  • (c)for the purchase of monovalent vaccines

    EUR 0,36 per dose;

  • (d)for the purchase of bivalent vaccines

    EUR 0,54 per dose;

  • (e)for the administration of vaccines to bovine animals

    EUR 1,80 per bovine animal vaccinated, regardless of the number and types of doses used;

  • (f)for the administration of vaccines to ovine or caprine animals

    EUR 0,90 per ovine or caprine animal vaccinated, regardless of the number and types of doses used.